Healthcare Costs of Pediatric Autism Spectrum Disorder in the United States, 2003–2015
- 28-10-2020
- Original Paper
- Auteurs
- Samuel H. Zuvekas
- Scott D. Grosse
- Tara A. Lavelle
- Matthew J. Maenner
- Patricia Dietz
- Xu Ji
- Gepubliceerd in
- Journal of Autism and Developmental Disorders | Uitgave 8/2021
share
DELEN
Deel dit onderdeel of sectie (kopieer de link)
-
Optie A:
-
Optie B:Deel de link per e-mail
Abstract
Published healthcare cost estimates for children with autism spectrum disorder (ASD) vary widely. One possible contributor is different methods of case ascertainment. In this study, ASD case status was determined using two sources of parent reports among 45,944 children ages 3–17 years in the Medical Expenditure Panel Survey (MEPS) linked to the National Health Interview Survey (NHIS) Sample Child Core questionnaire. In a two-part regression model, the incremental annual per-child cost of ASD relative to no ASD diagnosis was $3930 (2018 US dollars) using ASD case status from the NHIS Child Core and $5621 using current-year ASD case status from MEPS. Both estimates are lower than some published estimates but still represent substantial costs to the US healthcare system.
- Titel
- Healthcare Costs of Pediatric Autism Spectrum Disorder in the United States, 2003–2015
- Auteurs
-
Samuel H. Zuvekas
Scott D. Grosse
Tara A. Lavelle
Matthew J. Maenner
Patricia Dietz
Xu Ji
- Publicatiedatum
- 28-10-2020
- Uitgeverij
- Springer US
- Gepubliceerd in
-
Journal of Autism and Developmental Disorders / Uitgave 8/2021
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432 - DOI
- https://doi.org/10.1007/s10803-020-04704-z
Deze inhoud is alleen zichtbaar als je bent ingelogd en de juiste rechten hebt.
Deze inhoud is alleen zichtbaar als je bent ingelogd en de juiste rechten hebt.